TY - JOUR
T1 - Balance Right in Multiple Sclerosis (BRiMS)
T2 - a feasibility randomised controlled trial of a falls prevention programme
AU - Gunn, H.
AU - Stevens, K. N.
AU - Creanor, S.
AU - Andrade, J.
AU - Paul, L.
AU - Miller, L.
AU - Green, C.
AU - Ewings, P.
AU - Barton, A.
AU - Berrow, M.
AU - Vickery, J.
AU - Marshall, B.
AU - Zajicek, J.
AU - Freeman, J. A.
N1 - This study was funded by the NIHR Health Technology Assessment Programme (14/176/12), United Kingdom.
PY - 2021/1/4
Y1 - 2021/1/4
N2 - BackgroundBalance,
mobility impairments and falls are problematic for people with multiple
sclerosis (MS). The “Balance Right in MS (BRiMS)” intervention, a
13-week home and group-based exercise and education programme, aims to
improve balance and minimise falls. This study aimed to evaluate the
feasibility of undertaking a multi-centre randomised controlled trial
and to collect the necessary data to design a definitive trial.MethodsThis
randomised controlled feasibility study recruited from four United
Kingdom NHS clinical neurology services. Patients ≥ 18 years with
secondary progressive MS (Expanded Disability Status Scale 4 to 7)
reporting more than two falls in the preceding 6 months were recruited.
Participants were block-randomised to either a manualised 13-week
education and exercise programme (BRiMS) plus usual care, or usual care
alone.Feasibility assessment evaluated recruitment and retention
rates, adherence to group assignment and data completeness. Proposed
outcomes for the definitive trial (including impact of MS, mobility,
quality of life and falls) and economic data were collected at baseline,
13 and 27 weeks, and participants completed daily paper falls diaries.ResultsFifty-six
participants (mean age 59.7 years, 66% female, median EDSS 6.0) were
recruited in 5 months; 30 randomised to the intervention group. Ten
(18%) participants withdrew, 7 from the intervention group. Two
additional participants were lost to follow up at the final assessment
point. Completion rates were > 98% for all outcomes apart from the
falls diary (return rate 62%).After adjusting for baseline score,
mean intervention—usual care between-group differences for the
potential primary outcomes at week 27 were MS Walking Scale-12v2: − 7.7
(95% confidence interval [CI] − 17.2 to 1.8) and MS Impact Scale-29v2:
physical 0.6 (CI − 7.8 to 9), psychological − 0.4 (CI − 9.9 to 9). In
total, 715 falls were reported, rate ratio (intervention:usual care) for
falls 0.81 (0.41 to 2.26) and injurious falls 0.44 (0.41 to 2.23).ConclusionsProcedures
were practical, and retention, programme engagement and outcome
completion rates satisfied a priori progression criteria. Challenges
were experienced in completion and return of daily falls diaries.
Refinement of methods for reporting falls is therefore required, but we
consider a full trial to be feasible.Trial registration
ISRCTN13587999
AB - BackgroundBalance,
mobility impairments and falls are problematic for people with multiple
sclerosis (MS). The “Balance Right in MS (BRiMS)” intervention, a
13-week home and group-based exercise and education programme, aims to
improve balance and minimise falls. This study aimed to evaluate the
feasibility of undertaking a multi-centre randomised controlled trial
and to collect the necessary data to design a definitive trial.MethodsThis
randomised controlled feasibility study recruited from four United
Kingdom NHS clinical neurology services. Patients ≥ 18 years with
secondary progressive MS (Expanded Disability Status Scale 4 to 7)
reporting more than two falls in the preceding 6 months were recruited.
Participants were block-randomised to either a manualised 13-week
education and exercise programme (BRiMS) plus usual care, or usual care
alone.Feasibility assessment evaluated recruitment and retention
rates, adherence to group assignment and data completeness. Proposed
outcomes for the definitive trial (including impact of MS, mobility,
quality of life and falls) and economic data were collected at baseline,
13 and 27 weeks, and participants completed daily paper falls diaries.ResultsFifty-six
participants (mean age 59.7 years, 66% female, median EDSS 6.0) were
recruited in 5 months; 30 randomised to the intervention group. Ten
(18%) participants withdrew, 7 from the intervention group. Two
additional participants were lost to follow up at the final assessment
point. Completion rates were > 98% for all outcomes apart from the
falls diary (return rate 62%).After adjusting for baseline score,
mean intervention—usual care between-group differences for the
potential primary outcomes at week 27 were MS Walking Scale-12v2: − 7.7
(95% confidence interval [CI] − 17.2 to 1.8) and MS Impact Scale-29v2:
physical 0.6 (CI − 7.8 to 9), psychological − 0.4 (CI − 9.9 to 9). In
total, 715 falls were reported, rate ratio (intervention:usual care) for
falls 0.81 (0.41 to 2.26) and injurious falls 0.44 (0.41 to 2.23).ConclusionsProcedures
were practical, and retention, programme engagement and outcome
completion rates satisfied a priori progression criteria. Challenges
were experienced in completion and return of daily falls diaries.
Refinement of methods for reporting falls is therefore required, but we
consider a full trial to be feasible.Trial registration
ISRCTN13587999
KW - Secondary progressive multiple sclerosis
KW - Exercise
KW - Self-management
KW - Mobility
KW - Accidental falls
KW - Balance
KW - Quality of life
KW - Feasibility randomised controlled trial
UR - https://www.scopus.com/pages/publications/85098537358
U2 - 10.1186/s40814-020-00732-9
DO - 10.1186/s40814-020-00732-9
M3 - Article
SN - 2055-5784
VL - 7
JO - Pilot and Feasibility Studies
JF - Pilot and Feasibility Studies
IS - 1
M1 - 2
ER -